Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer (Q47894638)

6 February 2018

title

Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer (English)

1 reference

6 February 2018

author name string

R A de Jong

1

1 reference

6 February 2018

N Leffers

2

1 reference

6 February 2018

H M Boezen

3

1 reference

6 February 2018

K A ten Hoor

4

1 reference

6 February 2018

A G J van der Zee

5

1 reference

6 February 2018

H Hollema

6

1 reference

6 February 2018

H W Nijman

7

1 reference

6 February 2018

language of work or name

English

0 references

publication date

2 May 2009

1 reference

6 February 2018

published in

Gynecologic Oncology

1 reference

6 February 2018

volume

114

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

105-110

1 reference

6 February 2018

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

1 reference

7 January 2021

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Two pathogenetic types of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

CD4+ Tregs and immune control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Regulatory T cells in immune surveillance and treatment of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

High Number of Intraepithelial CD8+Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Effector memory T cells, early metastasis, and survival in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Tissue microarrays for high-throughput molecular profiling of tumor specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Control of regulatory T cell development by the transcription factor Foxp3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Vaccination against the Forkhead Family Transcription Factor Foxp3 Enhances Tumor Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.03.022

10.1016/J.YGYNO.2009.03.022

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018